M KATHLEEN BEHRENS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for M KATHLEEN BEHRENS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of M KATHLEEN BEHRENS. M KATHLEEN BEHRENS is a Director in Sarepta Therapeutics, Inc. ($SRPT) and a Director in ABGENIX INC ($ABGX) and a Director in MIMEDX GROUP, INC. ($AYXC.OB) and a Director in IGM Biosciences, Inc. ($IGMS).
Address: 6701 KAISER DRIVE FREMONT 94555 CA
Companies in which M KATHLEEN BEHRENS is an Insider
ABGENIX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of M KATHLEEN BEHRENS: Director
Holdings: 0 shares
Latest Transaction: Apr 04 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IGM Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of M KATHLEEN BEHRENS: Director
Holdings: 94,139 shares
Latest Transaction: Apr 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MIMEDX GROUP, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of M KATHLEEN BEHRENS: Director
Holdings: 38,135 shares
Latest Transaction: Aug 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sarepta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of M KATHLEEN BEHRENS: Director
Holdings: 135,517 shares
Current Value: $3,953,031
Latest Transaction: Mar 10 2021
$SRPT Market Capitalization: $1.60B
$SRPT Previous Close: $29.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of M KATHLEEN BEHRENS
Sentiment: All, ABGX, IGMS, AYXC.OB, SRPT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 211 | 0 | 94,139 | 93.9 K to 94.1 K (+0.22 %) |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | M | 42.30 | 5,000 | 211,500 | 0 | |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Sell | S | 85.76 | 5,000 | 428,800 | 130,517 | 135.5 K to 130.5 K (-3.69 %) |
| Mar 10 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | M | 42.30 | 5,000 | 211,500 | 135,517 | 130.5 K to 135.5 K (+3.83 %) |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 2,726 | 0 | 130,517 | 127.8 K to 130.5 K (+2.13 %) |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 |